CareDx (CDNA) Competitors $21.67 -1.11 (-4.87%) (As of 10:46 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CDNA vs. FLGT, PSNL, GTH, BNR, SHC, OPCH, SGRY, GH, BTSG, and PACSShould you be buying CareDx stock or one of its competitors? The main competitors of CareDx include Fulgent Genetics (FLGT), Personalis (PSNL), Genetron (GTH), Burning Rock Biotech (BNR), Sotera Health (SHC), Option Care Health (OPCH), Surgery Partners (SGRY), Guardant Health (GH), BrightSpring Health Services (BTSG), and PACS Group (PACS). CareDx vs. Fulgent Genetics Personalis Genetron Burning Rock Biotech Sotera Health Option Care Health Surgery Partners Guardant Health BrightSpring Health Services PACS Group CareDx (NASDAQ:CDNA) and Fulgent Genetics (NASDAQ:FLGT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, community ranking, dividends, profitability and media sentiment. Do analysts prefer CDNA or FLGT? CareDx presently has a consensus price target of $29.60, indicating a potential upside of 36.59%. Fulgent Genetics has a consensus price target of $28.50, indicating a potential upside of 56.68%. Given Fulgent Genetics' higher probable upside, analysts plainly believe Fulgent Genetics is more favorable than CareDx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CareDx 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43Fulgent Genetics 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has preferable valuation & earnings, CDNA or FLGT? Fulgent Genetics has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Fulgent Genetics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCareDx$280.32M4.15-$190.28M-$2.70-8.03Fulgent Genetics$289.21M1.92-$167.82M-$5.52-3.30 Is CDNA or FLGT more profitable? CareDx has a net margin of -45.90% compared to Fulgent Genetics' net margin of -59.39%. Fulgent Genetics' return on equity of -1.81% beat CareDx's return on equity.Company Net Margins Return on Equity Return on Assets CareDx-45.90% -53.70% -30.42% Fulgent Genetics -59.39%-1.81%-1.66% Does the MarketBeat Community favor CDNA or FLGT? CareDx received 196 more outperform votes than Fulgent Genetics when rated by MarketBeat users. Likewise, 66.17% of users gave CareDx an outperform vote while only 60.40% of users gave Fulgent Genetics an outperform vote. CompanyUnderperformOutperformCareDxOutperform Votes44066.17% Underperform Votes22533.83% Fulgent GeneticsOutperform Votes24460.40% Underperform Votes16039.60% Which has more volatility & risk, CDNA or FLGT? CareDx has a beta of 1.8, indicating that its stock price is 80% more volatile than the S&P 500. Comparatively, Fulgent Genetics has a beta of 1.51, indicating that its stock price is 51% more volatile than the S&P 500. Do insiders and institutionals hold more shares of CDNA or FLGT? 48.1% of Fulgent Genetics shares are held by institutional investors. 4.9% of CareDx shares are held by insiders. Comparatively, 31.8% of Fulgent Genetics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media favor CDNA or FLGT? In the previous week, Fulgent Genetics had 17 more articles in the media than CareDx. MarketBeat recorded 21 mentions for Fulgent Genetics and 4 mentions for CareDx. CareDx's average media sentiment score of 0.82 beat Fulgent Genetics' score of 0.34 indicating that CareDx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareDx 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fulgent Genetics 2 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryCareDx and Fulgent Genetics tied by winning 9 of the 18 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Get CareDx News Delivered to You Automatically Sign up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDNA vs. The Competition Export to ExcelMetricCareDxMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.16B$2.81B$5.18B$8.91BDividend YieldN/A1.68%4.98%4.03%P/E Ratio-8.0317.64135.1217.44Price / Sales4.15189.621,248.6491.11Price / CashN/A381.6138.8936.42Price / Book4.263.306.305.92Net Income-$190.28M-$32.88M$118.33M$224.86M7 Day Performance-9.25%-1.32%-1.54%-0.45%1 Month Performance-30.79%-1.24%2.98%4.16%1 Year Performance143.76%29.40%36.39%27.33% CareDx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDNACareDx4.0918 of 5 stars$21.67-4.9%$29.60+36.6%+187.6%$1.16B$280.32M-8.03740FLGTFulgent Genetics4.2152 of 5 stars$19.16-4.4%N/A-29.8%$586.05M$277.76M-3.471,184Analyst ForecastNews CoveragePSNLPersonalis4.0268 of 5 stars$5.23+6.3%N/A+343.9%$277.61M$73.48M-3.11400Analyst RevisionGap UpHigh Trading VolumeGTHGenetronN/A$4.03+0.2%N/A+8.9%$127.43M$94.34M0.00993High Trading VolumeBNRBurning Rock Biotech1.8405 of 5 stars$3.66+3.7%N/A-62.8%$37.48M$75.70M-0.761,390Short Interest ↓Positive NewsGap UpSHCSotera Health3.0194 of 5 stars$15.54-2.4%N/A+17.2%$4.40B$1.05B62.163,000OPCHOption Care Health4.9797 of 5 stars$22.850.0%N/A-21.9%$3.89B$4.30B19.207,802Insider BuyingShort Interest ↓SGRYSurgery Partners2.7516 of 5 stars$29.55-0.1%N/A-4.5%$3.76B$2.74B-109.4413,500Analyst ForecastGHGuardant Health4.6925 of 5 stars$29.68-0.2%N/A+39.7%$3.67B$563.95M-7.001,779Short Interest ↓BTSGBrightSpring Health Services2.9395 of 5 stars$19.54-2.5%N/AN/A$3.49B$8.83B-75.1535,000Short Interest ↓PACSPACS Group3.3069 of 5 stars$20.70+0.8%N/AN/A$3.15B$3.11B0.0032,433Gap Up Related Companies and Tools Related Companies Fulgent Genetics Alternatives Personalis Alternatives Genetron Alternatives Burning Rock Biotech Alternatives Sotera Health Alternatives Option Care Health Alternatives Surgery Partners Alternatives Guardant Health Alternatives BrightSpring Health Services Alternatives PACS Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CDNA) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CareDx, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share CareDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.